ACTU vs CFLT · $49.0M cap vs rev $963.6M
Actuate Therapeutics, Inc. Common stock (ACTU) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
ACTU currently screens at market cap $49.0M. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the ACTU and CFLT stock pages for the full models.
Not investment advice.